VIVUS Announces Date of Fourth Quarter and Year End 2013 Financial Results and
MOUNTAIN VIEW, Calif., Feb. 19, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc.
(Nasdaq:VVUS) today announced that it will report financial results for the
fourth quarter and year ended December 31, 2013 after the NASDAQ Market closes
on Monday, February 24, 2014. The company will conduct a conference call and
an audio webcast at 4:30pm EST the same day.
Date: February 24, 2014
Time: 1:30 PM PT
Listen via Internet: http://ir.vivus.com/
Schedule this webcast into MS-Outlook calendar (click open when prompted):
Toll-free: (877) 359-2916
International: ++(224) 357-2386
A webcast replay will be available on the VIVUS website for 30 days.
VIVUS is a biopharmaceutical company commercializing and developing
innovative, next-generation therapies to address unmet needs in obesity, sleep
apnea, diabetes and sexual health. For more information about the company,
please visit www.vivus.com.
Certain statements in this press release are forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995. These
statements may be identified by the use of forward-looking words such as
"anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely,"
"may," "plan," "potential," "predict," "opportunity" and "should," among
others. There are a number of factors that could cause actual events to differ
materially from those indicated by such forward-looking statements. VIVUS does
not undertake an obligation to update or revise any forward-looking
statements. Investors should read the risk factors set forth in VIVUS's Form
10-K for the year ending December 31, 2012, as amended by the Form 10-K/A
filed on April 30, 2013 and by the Form 10-K/A filed on June 12, 2013, and
periodic reports filed with the Securities and Exchange Commission.
CONTACT: VIVUS, Inc.
Dana B. Shinbaum, Corporate Development & Investor Relations
The Trout Group
Press spacebar to pause and continue. Press esc to stop.